540 related articles for article (PubMed ID: 4728043)
1. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
2. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
4. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
[TBL] [Abstract][Full Text] [Related]
5. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
7. Penicillamine and the SLE syndrome.
Walshe JM
J Rheumatol Suppl; 1981; 7():155-60. PubMed ID: 6939878
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
[TBL] [Abstract][Full Text] [Related]
9. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
[No Abstract] [Full Text] [Related]
10. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
[No Abstract] [Full Text] [Related]
11. A mechanism for the action of penicillamine in the treatment of Wilson's disease.
Peisach J; Blumberg WE
Mol Pharmacol; 1969 Mar; 5(2):200-9. PubMed ID: 4306792
[No Abstract] [Full Text] [Related]
12. Wilson's disease: modification by L-DOPA.
Gelmers HJ; Troost J; Willemse J
Neuropadiatrie; 1973 Dec; 4(4):453-7. PubMed ID: 4801897
[No Abstract] [Full Text] [Related]
13. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
Borthwick TR; Benson GD; Schugar HJ
J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013
[TBL] [Abstract][Full Text] [Related]
14. Patient with late-onset Wilson's disease: deterioration with penicillamine.
Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
[No Abstract] [Full Text] [Related]
15. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
16. Triethylene-tetramine (trien) therapy for Wilson's disease.
Saito H; Watanabe K; Sahara M; Mochizuki R; Edo K; Ohyama Y
Tohoku J Exp Med; 1991 May; 164(1):29-35. PubMed ID: 1926144
[TBL] [Abstract][Full Text] [Related]
17. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
18. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
19. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A
Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565
[No Abstract] [Full Text] [Related]
20. [Wilson's disease (hepatolenticular degeneration)].
Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
